Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.
Saved in:
| Title: | Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines. |
|---|---|
| Authors: | Sayed S; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Sürün D; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Mircetic J; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Sidorova OA; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Buchholz F; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany. frank.buchholz@tu-dresden.de.; National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ), Dresden, Germany. frank.buchholz@tu-dresden.de.; German Cancer Consortium (DKTK), Dresden, Germany. frank.buchholz@tu-dresden.de. |
| Source: | Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2508, pp. 235-260. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
